SEARCH

SEARCH BY CITATION

References

  • Allais A., Burel D. and Roy V. et al. (2010) Balanced effect of PACAP and FasL on granule cell death during cerebellar development: a morphological, functional and behavioural characterization. J. Neurochem. 113, 329340.
  • Bolanos J. P., Heales S. J., Peuchen S., Barker J. E., Land J. M. and Clark J. B. (1996) Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic. Biol. Med. 21, 9951001.
  • Brenneman D. E., Hauser J. M., Spong C. and Phillips T. M. (2002) Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity. Neuropeptides 36, 271280.
  • Brown D. R. and Mohn C. M. (1999) Astrocytic glutamate uptake and prion protein expression. Glia 25, 282292.
  • Castel H., Diallo M., Chatenet D. et al. (2006) Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes. J. Neurochem. 99, 582595.
  • Deguil J., Chavant F., Lafay-Chebassier C., Perault-Pochat M. C., Fauconneau B. and Pain S. (2010) Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice. Neurotox. Res. 17, 142155.
  • Dejda A., Sokolowska P. and Nowak J. Z. (2005) Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmacol. Rep. 57, 307320.
  • Dong Y., Liu H. D., Zhao R., Yang C. Z., Chen X. Q., Wang X. H., Lau L. T., Chen J. and Yu A. C. (2009) Ischemia activates JNK/c-Jun/AP-1 pathway to up-regulate 14-3-3γ in astrocyte. J. Neurochem. 109, 182188.
  • Dringen R., Gutterer J. M. and Hirrlinger J. (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267, 49124916.
  • Emerit J., Edeas M. and Bricaire F. (2004) Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58, 3946.
  • Falluel-Morel A., Aubert N., Vaudry D., Basille M., Fontaine M., Fournier A., Vaudry H. and Gonzalez B. J. (2004) Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J. Neurochem. 91, 12311243.
  • Feeney C. J., Frantseva M. V., Carlen P. L., Pennefather P. S., Shulyakova N., Shniffer C. and Mills L. R. (2008) Vulnerability of glial cells to hydrogen peroxide in cultured hippocampal slices. Brain Res. 1198, 115.
  • Ferrero-Gutierrez A., Perez-Gomez A., Novelli A. and Fernandez-Sanchez M. T. (2008) Inhibition of protein phosphatases impairs the ability of astrocytes to detoxify hydrogen peroxide. Free Radic. Biol. Med. 44, 18061816.
  • Fubini B. and Hubbard A. (2003) Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic. Biol. Med. 34, 15071516.
  • Hashimoto H., Kunugi A., Arakawa N. et al. (2003) Possible involvement of a cyclic AMP-dependent mechanism in PACAP-induced proliferation and ERK activation in astrocytes. Biochem. Biophys. Res. Commun. 311, 337343.
  • Huang T., Solano J., He D., Loutfi M., Dietrich W. D. and Kuluz J. W. (2009) Traumatic injury activates MAP kinases in astrocytes: mechanisms of hypothermia and hyperthermia. J. Neurotrauma 26, 15351545.
  • Jaworski D. M. (2000) Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury. Cell Tissue Res. 300, 219230.
  • Jolivel V., Basille M., Aubert N. et al. (2009) Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates. Neuroscience 160, 434451.
  • Joo K. M., Chung Y. H., Kim M. K., Nam R. H., Lee B. L., Lee K. H. and Cha C. I. (2004) Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J. Comp. Neurol. 476, 388413.
  • Kaur P., Aschner M. and Syversen T. (2007) Role of glutathione in determining the differential sensitivity between the cortical and cerebellar regions towards mercury-induced oxidative stress. Toxicology 230, 164177.
  • Lu M., Hu L. F., Hu G. and Bian J. S. (2008) Hydrogen sulfide protects astrocytes against H2O2-induced neural injury via enhancing glutamate uptake. Free Radic. Biol. Med. 45, 17051713.
  • Magistretti P. J., Cardinaux J. R. and Martin J. L. (1998) VIP and PACAP in the CNS: regulators of glial energy metabolism and modulators of glutamatergic signaling. Ann. N Y Acad. Sci. 865, 213225.
  • Masmoudi O., Gandolfo P., Leprince J., Vaudry D., Fournier A., Patte-Mensah C., Vaudry H. and Tonon M. C. (2003) Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism. FASEB J. 17, 1727.
  • Masmoudi-Kouki O., Gandolfo P., Castel H., Leprince J., Fournier A., Dejda A., Vaudry H. and Tonon M. C. (2007) Role of PACAP and VIP in astroglial functions. Peptides 28, 17531760.
  • May V., Lutz E., MacKenzie C., Schutz K. C., Dozark K. and Braas K. M. (2010) Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase γ and vesicle endocytosis for neuronal survival. J. Biol. Chem. 285, 97499761.
  • Miyata A., Arimura A., Dahl R. R., Minamino N., Uehara A., Jiang L., Culler M. D. and Coy D. H. (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164, 567574.
  • Moroo I., Tatsuno I., Uchida D., Tanaka T., Saito J., Saito Y. and Hirai A. (1998) Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates mitogen-activated protein kinase (MAPK) in cultured rat astrocytes. Brain Res. 795, 191196.
  • Nakamachi T., Nakamura K., Oshida K. et al. (2011) Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates proliferation of reactive astrocytes in vitro. J. Mol. Neurosci. 43, 1621.
  • Nishimoto M., Furuta A., Aoki S., Kudo Y., Miyakawa H. and Wada K. (2007) PACAP/PAC1 autocrine system promotes proliferation and astrogenesis in neural progenitor cells. Glia 55, 317327.
  • Ohtaki H., Nakamachi T., Dohi K. et al. (2006) Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc. Natl Acad. Sci. USA 103, 74887493.
  • Perez V., Bouschet T., Fernandez C., Bockaert J. and Journot L. (2005) Dynamic reorganization of the astrocyte actin cytoskeleton elicited by cAMP and PACAP: a role for phosphatidylInositol 3-kinase inhibition. Eur. J. Neurosci. 21, 2632.
  • Rana S. and Dringen R. (2007) Gap junction hemichannel-mediated release of glutathione from cultured rat astrocytes. Neurosci. Lett. 415, 4548.
  • Reynolds A., Laurie C., Mosley R. L. and Gendelman H. E. (2007) Oxidative stress and the pathogenesis of neurodegenerative disorders. Int. Rev. Neurobiol. 82, 297325.
  • Sandhu J. K., Gardaneh M., Iwasiow R., Lanthier P., Gangaraju S., Ribecco-Lutkiewicz M., Tremblay R., Kiuchi K. and Sikorska M. (2009) Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity. Neurobiol. Dis. 33, 405414.
  • Shieh P. C., Tsao C. W., Li J. S., Wu H. T., Wen Y. J., Kou D. H. and Cheng J. T. (2008) Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against β-amyloid-induced inhibition of rat brain astrocytes. Neurosci. Lett. 434, 15.
  • Shioda S., Ohtaki H., Suzuki R., Nakamachi T., Takenoya F., Dohi K. and Nakajo S. (2004) Prevention of delayed neuronal cell death by PACAP and its molecular mechanism. Nippon Yakurigaku Zasshi 123, 243252.
  • Shioda S., Ohtaki H., Nakamachi T. et al. (2006) Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment. Ann. N Y Acad. Sci. 1070, 550560.
  • Somogyvari-Vigh A. and Reglodi D. (2004) Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr. Pharm. Des. 10, 28612889.
  • Stumm R., Kolodziej A., Prinz V., Endres M., Wu D. F. and Hollt V. (2007) Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage. J. Neurochem. 103, 16661681.
  • Suzuki R., Arata S., Nakajo S., Ikenaka K., Kikuyama S. and Shioda S. (2003) Expression of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC1-R) in reactive astrocytes. Mol. Brain Res. 115, 1020.
  • Takuma K., Fujita T., Kimura Y. et al. (2000) T-588 inhibits astrocyte apoptosis via mitogen-activated protein kinase signal pathway. Eur. J. Pharmacol. 399, 18.
  • Takuma K., Baba A. and Matsuda T. (2004) Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol. 72, 111127.
  • Van Landeghem F. K., Weiss T., Oehmichen M. and von Deimling A. (2007) Cellular localization of pituitary adenylate cyclase-activating peptide (PACAP) following traumatic brain injury in humans. Acta Neuropathol. 113, 683693.
  • Vaudry D., Gonzalez B. J., Basille M., Fournier A. and Vaudry H. (1999) Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc. Natl Acad. Sci. USA 96, 94159420.
  • Vaudry D., Gonzalez B. J., Basille M., Pamantung T. F., Fontaine M., Fournier A. and Vaudry H. (2000) The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. Proc. Natl Acad. Sci. USA 97, 1339013395.
  • Vaudry D., Pamantung T. F., Basille M., Rousselle C., Fournier A., Vaudry H., Beauvillain J. C. and Gonzalez B. J. (2002) PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur. J. Neurosci. 15, 14511460.
  • Vaudry D., Falluel-Morel A., Bourgault S. et al. (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol. Rev. 61, 283357.